141 related articles for article (PubMed ID: 12584856)
1. [Three dimensional quantitative structure-activity relationship of heterocyclic-compounds with di-tert-bultylphenyl inhibitors].
Bai AP; Guo ZR; Chu FM
Yao Xue Xue Bao; 2001 May; 36(5):347-50. PubMed ID: 12584856
[TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2004 Aug; 14(15):4005-11. PubMed ID: 15225716
[TBL] [Abstract][Full Text] [Related]
3. A CoMFA study of COX-2 inhibitors with receptor based alignment.
Datar PA; Coutinho EC
J Mol Graph Model; 2004 Dec; 23(3):239-51. PubMed ID: 15530820
[TBL] [Abstract][Full Text] [Related]
4. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
Puntambekar DS; Giridhar R; Yadav MR
Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
[TBL] [Abstract][Full Text] [Related]
5. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
6. Partially unified multiple property recursive partitioning (PUMP-RP) analyses of cyclooxygenase (COX) inhibitors.
Rao SN; Stockfisch TP
J Chem Inf Comput Sci; 2003; 43(5):1614-22. PubMed ID: 14502496
[TBL] [Abstract][Full Text] [Related]
7. Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR.
Kotani T; Higashiura K
J Med Chem; 2004 May; 47(11):2732-42. PubMed ID: 15139751
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase (COX) inhibitors: a comparative QSAR study.
Garg R; Kurup A; Mekapati SB; Hansch C
Chem Rev; 2003 Mar; 103(3):703-32. PubMed ID: 12630850
[No Abstract] [Full Text] [Related]
9. [Three dimensional quantitative structure-activity relationship of a series of benzocylohepatpyridine farnesyltransferase inhibitors].
Wan SB; Yi X; Guo ZR
Yao Xue Xue Bao; 2002 Apr; 37(4):257-62. PubMed ID: 12579819
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation.
Srinath P; Rao PN; Knaus EE; Suresh MR
Anticancer Res; 2003; 23(5A):3923-8. PubMed ID: 14666698
[TBL] [Abstract][Full Text] [Related]
11. Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors.
Mozziconacci JC; Arnoult E; Bernard P; Do QT; Marot C; Morin-Allory L
J Med Chem; 2005 Feb; 48(4):1055-68. PubMed ID: 15715473
[TBL] [Abstract][Full Text] [Related]
12. Styrylheterocycles as a novel class inhibitor of cyclooxygenase-2-mediated prostaglandin E(2) production.
Lee SK; Park EJ; Lee E; Min HY; Kim EY; Lee T; Kim S
Bioorg Med Chem Lett; 2004 May; 14(9):2105-8. PubMed ID: 15080988
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR and preliminary evaluation of anti-inflammatory activity of series of N-pyrrolylcarboxylic acids.
Lessigiarska I; Nankov A; Bocheva A; Pajeva I; Bijev A
Farmaco; 2005 Mar; 60(3):209-18. PubMed ID: 15784239
[TBL] [Abstract][Full Text] [Related]
14. [Studied on docking of 5,6-diaryl-2,3-dihydro-1-pyrrolizinone derivatives with cyclooxygenase].
Zhao LQ; Hu YD; Yuan Y; Zhang T; Zhang SF; Li S
Yao Xue Xue Bao; 2001 Jun; 36(6):415-8. PubMed ID: 12585123
[TBL] [Abstract][Full Text] [Related]
15. [Three dimensional quantitative structure-activity relationship of farnesyl protein transferase inhibitors].
Wan SB; Yi X; Guo ZR
Yao Xue Xue Bao; 2001 Jun; 36(6):423-6. PubMed ID: 12585125
[TBL] [Abstract][Full Text] [Related]
16. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
Hsu N; Cai D; Damodaran K; Gomez RF; Keck JG; Laborde E; Lum RT; Macke TJ; Martin G; Schow SR; Simon RJ; Villar HO; Wick MM; Beroza P
J Med Chem; 2004 Sep; 47(20):4875-80. PubMed ID: 15369391
[TBL] [Abstract][Full Text] [Related]
17. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach.
Prasanna S; Manivannan E; Chaturvedi SC
Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946
[TBL] [Abstract][Full Text] [Related]
18. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
[TBL] [Abstract][Full Text] [Related]
19. Application of the novel molecular alignment method using the Hopfield Neural Network to 3D-QSAR.
Arakawa M; Hasegawa K; Funatsu K
J Chem Inf Comput Sci; 2003; 43(5):1396-402. PubMed ID: 14502472
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
Santagati A; Granata G; Marrazzo A; Santagati M
Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
